Lee Ainslie Day One Biopharmaceuticals, Inc. Transaction History
Maverick Capital LTD
- $4.82 Billion
- Q3 2024
A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Maverick Capital LTD holds 2,114,006 shares of DAWN stock, worth $28.8 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
2,114,006
Previous 1,211,138
74.55%
Holding current value
$28.8 Million
Previous $16.7 Million
76.45%
% of portfolio
0.61%
Previous 0.33%
Shares
3 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
84MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$107 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$87.6 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$80.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$66.4 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$61.7 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...